Recurrent venous thromboembolism and bleeding with extended anticoagulation: the VTE-PREDICT risk score
MA De Winter, HR Büller, M Carrier… - European heart …, 2023 - academic.oup.com
Aims Deciding to stop or continue anticoagulation for venous thromboembolism (VTE) after
initial treatment is challenging, as individual risks of recurrence and bleeding are …
initial treatment is challenging, as individual risks of recurrence and bleeding are …
[HTML][HTML] Prediction of risk of recurrence of venous thromboembolism following treatment for a first unprovoked venous thromboembolism: systematic review, prognostic …
Background Unprovoked first venous thromboembolism (VTE) is defined as VTE in the
absence of a temporary provoking factor such as surgery, immobility and other temporary …
absence of a temporary provoking factor such as surgery, immobility and other temporary …
[HTML][HTML] The absence ofminor'risk factors for recurrent venous thromboembolism: a systematic review of negative predictive values and negative likelihood ratios
K Meijer, S Schulman - Journal of Thrombosis and Haemostasis, 2009 - Elsevier
Background: The decision to stop anticoagulation after an episode of venous
thromboembolism (VTE) depends on the risk of recurrence. A number of recently discussed …
thromboembolism (VTE) depends on the risk of recurrence. A number of recently discussed …
Risk of recurrent venous thromboembolism: a Danish nationwide cohort study
IE Albertsen, PB Nielsen, M Søgaard… - The American Journal of …, 2018 - Elsevier
Purpose In this study, we aimed to estimate recurrence risk after incident venous
thromboembolism, stratified according to unprovoked, provoked, and cancer-related venous …
thromboembolism, stratified according to unprovoked, provoked, and cancer-related venous …
Identifying unprovoked thromboembolism patients at low risk for recurrence who can discontinue anticoagulant therapy
Background: Whether to continue oral anticoagulant therapy beyond 6 months after an
“unprovoked” venous thromboembolism is controversial. We sought to determine clinical …
“unprovoked” venous thromboembolism is controversial. We sought to determine clinical …
How I assess and manage the risk of bleeding in patients treated for venous thromboembolism
FA Klok, MV Huisman - Blood, The Journal of the American …, 2020 - ashpublications.org
For patients with venous thromboembolism (VTE), prediction of bleeding is relevant
throughout the course of treatment, although the means and goal of this prediction differ …
throughout the course of treatment, although the means and goal of this prediction differ …
[HTML][HTML] Risk prediction of recurrent venous thrombosis; where are we now and what can we add?
JF Timp, WM Lijfering, FR Rosendaal… - Journal of Thrombosis …, 2019 - Elsevier
Background Several models are available to predict recurrent venous thrombosis (VT) in
patients with unprovoked first events. Objectives To validate these prediction models …
patients with unprovoked first events. Objectives To validate these prediction models …
[HTML][HTML] Bleeding risk assessment in patients with venous thromboembolism
The recommended treatment for patients with venous thromboembolism (VTE) is
anticoagulation for at least 3 months. However, anticoagulant treatment increases the risk of …
anticoagulation for at least 3 months. However, anticoagulant treatment increases the risk of …
Individualised risk assessments for recurrent venous thromboembolism: new frontiers in the era of direct Oral anticoagulants
J Wang, HY Lim, P Ho - Hemato, 2021 - mdpi.com
Venous thromboembolism (VTE) is a leading cause of morbidity and mortality and is
associated with high recurrence rates. The introduction of direct oral anticoagulants …
associated with high recurrence rates. The introduction of direct oral anticoagulants …
Tailored anticoagulant treatment after a first venous thromboembolism: protocol of the Leiden Thrombosis Recurrence Risk Prevention (L-TRRiP) study-cohort-based …
JLI Burggraaf-van Delft, N van Rein… - BMJ open, 2024 - bmjopen.bmj.com
Introduction Patients with a first venous thromboembolism (VTE) are at risk of recurrence.
Recurrent VTE (rVTE) can be prevented by extended anticoagulant therapy, but this comes …
Recurrent VTE (rVTE) can be prevented by extended anticoagulant therapy, but this comes …